AI is being used to pre-empt risk for colon cancer

Artificial intelligence has made some great developments toward speeding up cancer diagnosis so far in 2017. Last month it was announced that AI from Sophia Genetics was helping to accelerate patient diagnosis across Latin America. Earlier this year researchers at Stanford University developed a deep learning algorithm that can analyse skin cancer as accurately as a human doctor. Now, Israel-based company, Medical EarlySign has announced the ability of its AI tool to identify the top 1% at highest risk of undiagnosed colorectal cancer (CRC). The machine learning developer announced the first-year results of its implementation with Maccabi Healthcare Services (MHS), for ColonFlag, a tool developed in collaboration with MHS to identify individuals with a high probability of having CRC.